Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases

Cardiovascular and metabolic disease (CMD) remains a main cause of premature death worldwide. Berberine (BBR), a lipid-lowering botanic compound with diversified potency against metabolic disorders, is a promising candidate for ameliorating CMD. The liver is the target of BBR so that liver-site accu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Guo, Hui-Hui, Feng, Chen-Lin, Zhang, Wen-Xuan, Luo, Zhi-Gang, Zhang, Hong-Juan, Zhang, Ting-Ting, Ma, Chen, Zhan, Yun, Li, Rui, Wu, Song, Abliz, Zeper, Li, Cong, Li, Xiao-Lin, Ma, Xiao-Lei, Wang, Lu-Lu, Zheng, Wen-Sheng, Han, Yan-Xing, Jiang, Jian-Dong
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491597/
https://ncbi.nlm.nih.gov/pubmed/31040273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-019-09852-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars